- Home
- GNS vs SRZN Comparison
GNS vs SRZN Comparison
Compare GNS & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNS
- SRZN
- Stock Information
- Founded
- GNS 2002
- SRZN 2015
- Country
- GNS Singapore
- SRZN United States
- Employees
- GNS N/A
- SRZN N/A
- Industry
- GNS Other Consumer Services
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- GNS Real Estate
- SRZN Health Care
- Exchange
- GNS Nasdaq
- SRZN Nasdaq
- Market Cap
- GNS 24.2M
- SRZN 38.1M
- IPO Year
- GNS 2022
- SRZN N/A
- Fundamental
- Price
- GNS $0.30
- SRZN $12.00
- Analyst Decision
- GNS
- SRZN Strong Buy
- Analyst Count
- GNS 0
- SRZN 2
- Target Price
- GNS N/A
- SRZN $38.50
- AVG Volume (30 Days)
- GNS 5.3M
- SRZN 14.2K
- Earning Date
- GNS 12-27-2024
- SRZN 05-07-2025
- Dividend Yield
- GNS N/A
- SRZN N/A
- EPS Growth
- GNS N/A
- SRZN N/A
- EPS
- GNS N/A
- SRZN N/A
- Revenue
- GNS $16,147,348.00
- SRZN $10,000,000.00
- Revenue This Year
- GNS N/A
- SRZN N/A
- Revenue Next Year
- GNS $47.43
- SRZN N/A
- P/E Ratio
- GNS N/A
- SRZN N/A
- Revenue Growth
- GNS N/A
- SRZN N/A
- 52 Week Low
- GNS $0.29
- SRZN $6.00
- 52 Week High
- GNS $6.97
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- GNS 33.52
- SRZN 49.35
- Support Level
- GNS $0.31
- SRZN $11.11
- Resistance Level
- GNS $0.41
- SRZN $12.00
- Average True Range (ATR)
- GNS 0.05
- SRZN 0.71
- MACD
- GNS -0.00
- SRZN 0.05
- Stochastic Oscillator
- GNS 9.49
- SRZN 53.61
About GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education - entrepreneur education, management consultancy, and business development tools; and Campus - resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).